Why the study?
Should oral anticoagulation be resumed after anticoagulation-associated intracerebral hemorrhage?
Should oral anticoagulation be resumed after anticoagulation-associated intracerebral hemorrhage?
This review discusses the clinical dilemma and management strategies regarding the resumption of oral anticoagulation after an anticoagulation-associated intracerebral hemorrhage.
Resuming oral anticoagulation after anticoagulation-associated intracerebral hemorrhage requires individualized assessment; leaves open optimal timing and selection pending randomized data.
Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation-associated ICH.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: